LU92174I2 - Acide zolédronique ou son sel pharmaceutiquement acceptable ou tout hydrate de celui-ci - Google Patents

Acide zolédronique ou son sel pharmaceutiquement acceptable ou tout hydrate de celui-ci

Info

Publication number
LU92174I2
LU92174I2 LU92174C LU92174C LU92174I2 LU 92174 I2 LU92174 I2 LU 92174I2 LU 92174 C LU92174 C LU 92174C LU 92174 C LU92174 C LU 92174C LU 92174 I2 LU92174 I2 LU 92174I2
Authority
LU
Luxembourg
Prior art keywords
hydrate
pharmaceutically acceptable
acceptable salt
zoledronic acid
zoledronic
Prior art date
Application number
LU92174C
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32595500&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU92174(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of LU92174I2 publication Critical patent/LU92174I2/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU92174C 2000-06-20 2013-03-22 Acide zolédronique ou son sel pharmaceutiquement acceptable ou tout hydrate de celui-ci LU92174I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59713500A 2000-06-20 2000-06-20

Publications (1)

Publication Number Publication Date
LU92174I2 true LU92174I2 (fr) 2013-05-22

Family

ID=32595500

Family Applications (1)

Application Number Title Priority Date Filing Date
LU92174C LU92174I2 (fr) 2000-06-20 2013-03-22 Acide zolédronique ou son sel pharmaceutiquement acceptable ou tout hydrate de celui-ci

Country Status (6)

Country Link
EP (1) EP1591122B1 (fr)
DK (1) DK1591122T3 (fr)
LU (1) LU92174I2 (fr)
RU (1) RU2288722C2 (fr)
SI (2) SI1296689T1 (fr)
ZA (1) ZA200210361B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012001349B8 (pt) * 2009-07-21 2021-05-25 Mylan Inc processo livre de solvente para produzir uma composição adesiva
US9169279B2 (en) 2009-07-31 2015-10-27 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
US20160016982A1 (en) 2009-07-31 2016-01-21 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
EP2459176B1 (fr) 2009-07-31 2017-09-27 Grünenthal GmbH Procédé de cristallisation et biodisponibilité
RU2415145C1 (ru) * 2009-09-15 2011-03-27 Закрытое Акционерное Общество "Фарм-Синтез" Способ получения золедроновой кислоты
US9340565B2 (en) 2010-11-24 2016-05-17 Thar Pharmaceuticals, Inc. Crystalline forms
US10195218B2 (en) 2016-05-31 2019-02-05 Grunenthal Gmbh Crystallization method and bioavailability

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4A (en) * 1836-08-10 Thomas Blanchard Stock shaving or rounding machine for edges ends etc of ships' tackle-blocks
US5A (en) * 1836-08-10 Thomas Blanchard Machine for mortising solid wooden shells of ships' tackle-blocks
DE3776880D1 (de) 1986-11-21 1992-04-02 Ciba Geigy Ag Neue substituierte alkandiphosphonsaeuren.
DE69329199D1 (de) * 1992-05-29 2000-09-14 Procter & Gamble Pharma Schwefel-enthaltende phosphonat-verbindungen zur behandlung von abnormalem calzium- und phosphat- metabolismus
GB9408775D0 (en) 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
PT1175904E (pt) * 1997-07-22 2007-04-30 Merck & Co Inc Alendronato para utilização no tratamento da osteoporose
US6015801A (en) * 1997-07-22 2000-01-18 Merck & Co., Inc. Method for inhibiting bone resorption
FI109088B (fi) * 1997-09-19 2002-05-31 Leiras Oy Tabletti ja menetelmä sen valmistamiseksi
SE9703691D0 (sv) * 1997-10-10 1997-10-10 Astra Ab Pharmaceutical compositions
IT1296495B1 (it) * 1997-11-21 1999-06-25 Prodotti Antibiotici Spa Impiego di bisfosfonati nella preparazione di forme farmaceutiche per somministrazione intramuscolare
PT1178810E (pt) * 1999-05-21 2005-08-31 Novartis Ag Utilizacao de acidos bisfosfonicos para o tratamento de angiogenese

Also Published As

Publication number Publication date
ZA200210361B (en) 2003-11-13
SI1296689T1 (sl) 2006-08-31
DK1591122T3 (da) 2013-02-25
EP1591122B1 (fr) 2012-09-26
EP1591122A1 (fr) 2005-11-02
SI1591122T1 (sl) 2013-02-28
RU2288722C2 (ru) 2006-12-10

Similar Documents

Publication Publication Date Title
LU92174I2 (fr) Acide zolédronique ou son sel pharmaceutiquement acceptable ou tout hydrate de celui-ci
LU92397I2 (fr) Vortioxétine ou un sel d'addition d'acide de celui-ci pharmaceutiquement acceptable
DE10085137T1 (de) Chirurgischer Sensor
DE60126038D1 (de) Chirurgisches Ultraschallsystem
DE69909135D1 (de) Orale zubereitung zur bekämpfung von mundgeruch
DE60043793D1 (de) Dreidimensionales lenkbares System
DE60024273D1 (de) Chirurgische zugangsvorrichtung
DE60204196D1 (de) Endoskopisches System
DE60125769D1 (de) Verbessertes elektroentionisierungssystem
NO20030422D0 (no) Vaginal avlevering av bisfosfonater
DE60140462D1 (de) Darreichungsform zur hormonalen kontrazeption
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
DE60019672D1 (de) Flacher Fussschalter
FR2802447B1 (fr) Systeme vaporisateur rechargeable
EP1317933A4 (fr) Preparation pour pansements
NO20013213D0 (no) Sonarsystem for bestemmelse av fiskestörrelse
DK1031288T3 (da) Mælkemineralpræparat
PL360432A1 (pl) Układ czujnika
NO20016137D0 (no) System for festing av tauekrok
FR2810511B1 (fr) Chausson lavable pour article chaussant
DE50005386D1 (de) Aminophosphoniumverbindungen
DE60117330D1 (de) Gerät zur Verwaltung des weiblichen physischen Zustands
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
DE60143769D1 (de) Elektronisch geregeltes Bremssystem
FR2818624B1 (fr) Systeme de manutention